The Role of Percentage of Prostate-specific Antigen Reduction After Focal Therapy Using High-intensity Focused Ultrasound for Primary Localised Prostate Cancer. Results from a Large Multi-institutional Series
Armando Stabile, Clément Orczyk, Francesco Giganti, Marco Moschini, Clare Allen, Shonit Punwani, Nathalie Cathala, Hashim U. Ahmed, Xavier Cathelineau, Francesco Montorsi, Mark Emberton, Alberto Briganti, Rafael Sanchez‐Salas, Caroline M. Moore
Topics & Concepts
MedicineProstate cancerProstate-specific antigenUrologyProstateHazard ratioStage (stratigraphy)Proportional hazards modelCohortInternal medicineCancerOncologyConfidence intervalPaleontologyBiologyProstate Cancer Diagnosis and TreatmentProstate Cancer Treatment and ResearchUrinary Bladder and Prostate Research